These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 20504283)

  • 1. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.
    Ghannam S; Bouffi C; Djouad F; Jorgensen C; Noël D
    Stem Cell Res Ther; 2010 Mar; 1(1):2. PubMed ID: 20504283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory effect of mesenchymal stem cells.
    Herrero C; Pérez-Simón JA
    Braz J Med Biol Res; 2010 May; 43(5):425-30. PubMed ID: 20490429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune properties of mesenchymal stem cells.
    Sotiropoulou PA; Papamichail M
    Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells: a new strategy for immunosuppression?
    Uccelli A; Pistoia V; Moretta L
    Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host Disease.
    Tang B; Li X; Liu Y; Chen X; Li X; Chu Y; Zhu H; Liu W; Xu F; Zhou F; Zhang Y
    Cell Physiol Biochem; 2018; 46(6):2624-2635. PubMed ID: 29763906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
    Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
    Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
    Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
    Front Immunol; 2019; 10():619. PubMed ID: 31001253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of the immunosuppressive properties of mesenchymal stromal cells.
    de Castro LL; Lopes-Pacheco M; Weiss DJ; Cruz FF; Rocco PRM
    J Mol Med (Berl); 2019 May; 97(5):605-618. PubMed ID: 30903229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of mesenchymal stem cells for the therapy of autoimmune diseases.
    Pistoia V; Raffaghello L
    Expert Rev Clin Immunol; 2010 Mar; 6(2):211-8. PubMed ID: 20402384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of inflammatory diseases with mesenchymal stem cells.
    Newman RE; Yoo D; LeRoux MA; Danilkovitch-Miagkova A
    Inflamm Allergy Drug Targets; 2009 Jun; 8(2):110-23. PubMed ID: 19530993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.
    Amorin B; Alegretti AP; Valim V; Pezzi A; Laureano AM; da Silva MA; Wieck A; Silla L
    Hum Cell; 2014 Oct; 27(4):137-50. PubMed ID: 24903975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
    Introna M; Golay J
    Front Immunol; 2020; 11():609063. PubMed ID: 33362797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cells in transplantation rejection and tolerance.
    English K; Wood KJ
    Cold Spring Harb Perspect Med; 2013 May; 3(5):a015560. PubMed ID: 23637312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.
    Djouad F; Plence P; Bony C; Tropel P; Apparailly F; Sany J; Noël D; Jorgensen C
    Blood; 2003 Nov; 102(10):3837-44. PubMed ID: 12881305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications.
    Castro-Manrreza ME; Montesinos JJ
    J Immunol Res; 2015; 2015():394917. PubMed ID: 25961059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9.
    Fan J; Tang X; Wang Q; Zhang Z; Wu S; Li W; Liu S; Yao G; Chen H; Sun L
    Stem Cell Res Ther; 2018 Sep; 9(1):237. PubMed ID: 30223894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
    Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.